Sodium Bicarbonate Injection Shortage: Latest Availability and Manufacturer Updates

What’s in Shortage

Sodium Bicarbonate Injection (Brand Name: SODIUM BICARBONATE) is currently listed in shortage by the FDA. This medication is an injection used within therapeutic categories including Endocrinology/Metabolism, Gastroenterology, and Pediatrics.

Current Status: Current
Initial Posting Date: 07/24/2017
Last Updated: 02/02/2026

Which Manufacturers Are Affected

Availability varies by manufacturer and specific concentration:

• Exela Pharma Sciences, LLC

  • Status: Available
  • Presentations:
    • 84 mg/1 mL (NDC 51754-5011-4)
    • 84 mg/1 mL (NDC 51754-5001-5)
    • 42 mg/1 mL (NDC 51754-5012-4)
  • Contact Info: 828-758-5474 ext. 154

• Fresenius Kabi USA, LLC

  • Status: Mixed Availability
  • Presentations:
    • 84 mg/1 mL (NDC 63323-089-50): Available (Note: Check wholesalers for inventory)
    • 42 mg/1 mL (NDC 63323-083-05): Unavailable (Note: Next release not available at this time. Check wholesalers for inventory.)
  • Contact Info: 888-386-1300

Why There’s a Shortage

No specific reason for the shortage of Sodium Bicarbonate Injection was provided in the source data.

What Patients Should Do

If you or a loved one are prescribed Sodium Bicarbonate Injection, please consider the following steps:

• Consult Your Healthcare Provider: Discuss the shortage with your doctor to understand how it may affect your treatment plan.
• Speak with a Pharmacist: Pharmacists often have the most up-to-date information on local stock and wholesaler availability.
• Contact Manufacturers: You may use the contact information listed above to inquire about supply timelines for specific presentations.

Disclaimer: This article is for informational purposes only. Patients should always consult with their healthcare provider or a qualified medical professional regarding medication changes or health concerns.

Source

Information provided by the FDA Drug Shortage Database.